[2] |
Mizoshita T,Kataoka H,Kubota E,et al.Gastricphenotype signetring cell carcinoma of the stomach with multiple bone metastases effectively treated with sequential meth-otrexate and 5-fluorouracil[J].Int J Clin Oncol,2008,13﹙4﹚:373.
|
[3] |
Glimelius B,Ekstrom K,Hoffman K,et al.Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer [J].Ann Oncol,1997,8(2):163-168.
|
[1] |
Parkin D M,Bray F,Ferlay J,et al.Global cancer statistics[J].C A Cancer J Clin,2005,55﹙2﹚:74.
|
[4] |
Alberts S R,Cervantes A,VANDE Velde C J,et al .Gastric cancer: epidemiology,pathology and treatment [J].Ann Oncol,2003,14(suppl 2):S31.
|
[2] |
Mizoshita T,Kataoka H,Kubota E,et al.Gastricphenotype signetring cell carcinoma of the stomach with multiple bone metastases effectively treated with sequential meth-otrexate and 5-fluorouracil[J].Int J Clin Oncol,2008,13﹙4﹚:373.
|
[3] |
Glimelius B,Ekstrom K,Hoffman K,et al.Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer [J].Ann Oncol,1997,8(2):163-168.
|
[5] |
Sato A,Ito T,Tomita T.Chemotherapy of gastric cancer-a review of clinical trials in Japan 2002[J].Gan To Kaggku Ryobo,2002,29﹙9﹚:1522.
|
[6] |
白坂哲彦,佃守犬山,扶他新规.经口抗癌剂TS-1(S-1)[J].癌症化学疗法,2001,28(6):855.
|
[4] |
Alberts S R,Cervantes A,VANDE Velde C J,et al .Gastric cancer: epidemiology,pathology and treatment [J].Ann Oncol,2003,14(suppl 2):S31.
|
[7] |
Koizumi W, Akiya T, Sato A, et al. Phase Ⅱ study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo Cooperative Oncology Group study [J]. Cancer Chemother Pharmacol,2010,65(6):1093-1099.
|
[5] |
Sato A,Ito T,Tomita T.Chemotherapy of gastric cancer-a review of clinical trials in Japan 2002[J].Gan To Kaggku Ryobo,2002,29﹙9﹚:1522.
|
[8] |
Koizumi W.S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer.(SPIRITS trial):a phase III trial [J].Lancet Oncol,2008,9(3):215.
|
[6] |
白坂哲彦,佃守犬山,扶他新规.经口抗癌剂TS-1(S-1)[J].癌症化学疗法,2001,28(6):855.
|
[7] |
Koizumi W, Akiya T, Sato A, et al. Phase Ⅱ study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo Cooperative Oncology Group study [J]. Cancer Chemother Pharmacol,2010,65(6):1093-1099.
|
[9] |
Boku N.Chemotherapy for metastatic disease:review from JCOG trial[J].International Journal of Clinical Oncology,2008,13(3):196.
|
[8] |
Koizumi W.S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer.(SPIRITS trial):a phase III trial [J].Lancet Oncol,2008,9(3):215.
|
[10] |
Al Batran S E,Atmaca A,Hegewisch-Becker S,et al. Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer [J]. J Clin Oncol,2004;22:658-663.
|
[9] |
Boku N.Chemotherapy for metastatic disease:review from JCOG trial[J].International Journal of Clinical Oncology,2008,13(3):196.
|
[11] |
张晓南,卞晓山,魏长宏,等.国产奥沙利铂联合亚叶酸钙和氟尿嘧啶治疗晚期胃癌42例[J].武警医学,2006,17(6):447.
|
[10] |
Al Batran S E,Atmaca A,Hegewisch-Becker S,et al. Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer [J]. J Clin Oncol,2004;22:658-663.
|
[11] |
张晓南,卞晓山,魏长宏,等.国产奥沙利铂联合亚叶酸钙和氟尿嘧啶治疗晚期胃癌42例[J].武警医学,2006,17(6):447.
|